home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Stopping Cell Death Speeds Spinal Injury Recovery

 
  March, 16 2004 9:21
your information resource in human molecular genetics
 
     
Spinal cord injuries (SCIs) can have devastating consequences that are difficult to reverse. Researchers are actively pursuing ways to restore movement and sensation to SCI patients. Blocking a protein involved in cell death could be one way to treat SCIs, according to a report in the April issue of Nature Medicine.

Ana Martin-Villalba and coworkers targeted a protein called CD95L, part of a system that causes cells to self-destruct. Patients' prognoses depend in part on how much secondary damage is caused by this cell-death system. The researchers simulated injuries in patients by cutting the spinal cords of mice and paralyzing them. When the researchers used antibodies to block CD95L, significantly fewer cells died, and the injured nerve cells were able to regenerate, allowing the once-paralyzed mice to recover their motor ability.

Treatment of SCI is a complex problem that will probably require multiple therapies, but the authors suggest that blocking CD95L might be one potential treatment.

Author contact:

Ana Martin-Villalba
German Cancer Research Center
Heidelberg, Germany
Tel: +49 6221 423766
E-mail: a.martin-villalba@dkfz.de

Also available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.